Arbutus Biopharma Corporation Stock Performance

Open $4.19	Prev. Close $4.30	Circuit Range N/A
Day Range $4.05 - $4.22	Year Range $3.56 - $5.38	Volume 3,40,031
Average Traded $4.14

Arbutus Biopharma Corporation Share Price Today

As of 9 October 2026, Arbutus Biopharma Corporation's share price is $4.17. The stock opened at $4.19, compared to its previous close of $4.30. During today's trading session, Arbutus Biopharma Corporation's share price traded between $4.05 and $4.22, with an average price of $4.14. Over the past 52 weeks, the stock has recorded a high of $5.38 and a low of $3.56. In terms of performance, Arbutus Biopharma Corporation's share price has declined by 0.83% over the last six months and is down 11.64% on a year-on-year basis.

Arbutus Biopharma Corporation Share Price Chart

$4.05$4.22

Arbutus Biopharma Corporation Stock Fundamentals & Key Indicators

Market Cap $799.93M	PE Ratio (TTM) 5.55	Dividend Yield 0.00%
EPS (TTM) $0.77	Revenue (TTM) $14.08B	Return On Equity (TTM) 59.14%
Profit Margin -237.93%	Debt to Equity 0.01	Quarterly Earnings Growth YoY 32.95%

Arbutus Biopharma Corporation Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$0.53	$1.05	$179.13	$1.01
Net Profit	-$7.74	-$3.76	$169.70	-$5.19
Net Profit Margin	-1460.38%	-358.10%	94.74%	-513.86%
Income Change	N/A	51.42%	4613.30%	-103.06%

Arbutus Biopharma Corporation Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$39.02	$18.14	$6.17	$14.08
Net Profit	-$69.46	-$72.85	-$69.92	-$33.50
Net Profit Margin	-178.01%	-401.60%	-1133.23%	-237.93%
Income Change	N/A	-4.88%	4.02%	52.09%

About Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Arbutus Biopharma Corporation Historical Returns

Month	Open	Close	Change %
Oct 2026	$4.76	$4.21	-12.03%
Sep 2026	$5.09	$4.78	-7.36%
Aug 2026	$4.34	$5.16	+18.62%
Jul 2026	$4.84	$4.35	-9.38%
Jun 2026	$4.47	$4.80	+5.49%
May 2026	$4.17	$4.55	+8.08%
Apr 2026	$4.53	$4.21	-6.24%
Mar 2026	$4.55	$4.49	-3.65%
Feb 2026	$4.09	$4.66	+12.56%
Jan 2026	$4.84	$4.14	-14.11%
Dec 2025	$4.31	$4.82	+9.55%
Nov 2025	$4.68	$4.40	-6.88%

ABUS Share Price FAQs

What is Arbutus Biopharma Corporation share price today?

Arbutus Biopharma Corporation share price today is $4.17 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Arbutus Biopharma Corporation stock?

The 52 week high of Arbutus Biopharma Corporation stock is $5.38, while the 52 week low is $3.56 as of 9 Oct '26.

What is ABUS's market capitalisation today?

ABUS market capitalisation is $799.93M as of October 9, 2026, at 6:20 am IST.

What is ABUS's net income for the last quarter?

ABUS's net income for the last quarter is -5.19B USD.

What is the 5 year returns of ABUS?

The 5 year returns of ABUS is 3.88% as on 9 Oct '26.

What is the high & low stock price of ABUS today?

ABUS stock price hit a high of $4.22 and low of $4.05 as of 9 Oct '26.

Can I buy ABUS shares in India?

Yes. You can buy ABUS in India by opening an international trading account.